Article
Dual-mechanism therapy for chronic rhinosinusitis via siRNA targeting of bacterial 16S rRNA and disruption of CFTR-pathogen interactions.
Brazilian journal of otorhinolaryngology - 1 Jan 2026
Wei Bo, He Jiaoyu, Li Jiaxin, Liu Feng
Abstract excerpt
OBJECTIVE(S): This study aimed to develop a dual-mechanism therapeutic strategy for Chronic Rhinosinusitis (CRS) associated with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutations. Specifically, we sought to (1) Design siRNAs targeting conserved regions of the bacterial 16S rRNA gene to reduce pathogen viability and (2) Investigate the interaction between mutant CFTR (PDB: 1XMJ) and a bacterial...
Read the complete abstract on PubMedTopics
- Rhinosinusitis
- Cystic Fibrosis Transmembrane Conductance Regulator
- Humans
- RNA, Small Interfering
- RNA, Ribosomal, 16S
- Biofilms
